|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, December 06, 2017 ) North America Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market Outline: North America Hemostasis Diagnostics Market
Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.
A sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/north-america-hemostasis-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx
Market Dynamics: North America Hemostasis Diagnostics Market
Increase in the prevalence of hemophilia disease in U.S. and Canada (according to Canadian Hemophilia Society, approximately 35,000 Canadians are having an inherited bleeding disorder gene), rise in number of surgeries, technological advancements in the hemostasis diagnostics such as accurate results in less time, and rise in R&D investment for novel tests and devices innovation are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market.
Market Scope: North America Hemostasis Diagnostics Market
Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user
Based on the product type, market is segmented into the following:
Systems
Consumables
Point-of-Care Testing Devices
Based on the test type, market is segmented into the following:
Fibrinogen Test
Activated Clotting Time
Platelet Function
Prothrombin Time
Heparin & Protamine Dose-Response Test For ACT
Activated Partial Thromboplastin Time
Anti-Factor Xa
Other Coagulation Tests
To view TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/north-america-hemostasis-diagnostics-market/#ulp-c654SbFYO64MsOhu
Based on the technology, market is segmented into the following:
Optical
Mechanical
Electrochemical
Others
Based on the end user, market is segmented into the following:
Hospitals
Clinics
Diagnostic Centres
Others (POC)
Regional Analysis: North America Hemostasis Diagnostics Market
Geographically, North America hemostasis diagnostics market has been segmented into U.S. and Canada. U.S. hemostasis diagnostics market is projected to grow at a significant CAGR owing to increase in the prevalence of hemophilia disease. For instance, according to Centre for Disease Control and Prevention 2015, approximately 20,000 people are suffering from hemophilia in U.S., increase in the R&D activities for the development of newer tests, and FDA clearance for the newer diagnostics tests are anticipated to fuel the market. Canada hemostasis diagnostics market expected to grow at notable rate due to increase in the prevalence of hemophilia disease, rise in prevalence & incidence of various cardiovascular diseases and expansion of business by the market players in Canada are expected to propel the market. For instance, in February 2012, Roche collaborated with Technoclone to expand the reagent portfolio for coagulation diagnostics in US and Canada.
Need more information about this report @https://www.precisionbusinessinsights.com/market-reports/north-america-hemostasis-diagnostics-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: North America Hemostasis Diagnostics Market
Some of the players in the North America hemostasis diagnostics market include:
Hoffmann-La Roche Ltd. (Switzerland)
Sysmex Corporation (Japan)
Abbott Laboratories (U.S.)
Alere Inc. (U.S.)
Nihon Kohden Corporation (Japan)
Siemens Healthineers (Germany)
Danaher Corporation (U.S.)
Instrumentation Laboratory (U.S.)
Grifols S.A (Spain)
Beckman Coulter, Inc. (U.S.)
Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/north-america-hemostasis-diagnostics-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
Precision Business Insights
Sales
+1-866-598-1553
sales@precisionbusinessinsights.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
